Trademark Overview
On Wednesday, April 15, 2015, a trademark application was filed for ATTSITE with the United States Patent and Trademark Office. The USPTO has given the ATTSITE trademark a serial number of 86598934. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 7, 2016. This trademark is owned by Intrexon Corporation. The ATTSITE trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture, food production, energy conversion, and production of environmentally-friendly chemical solutions; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; Chemical modifiers of gene expression in plants, mammals, fungi and microbes for industrial and agricultural applications; Chemicals and chemical reagents, namely, for production of cells and transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research
Chemical modifiers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes
Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, and special purpose cells to the specifications of others for scientific, research, medical and laboratory use
Development of new technology for others in the fields of medicine, genetics, therapeutics, biotechnology, agriculture, energy, fuels, biofuels, biochemistry, the chemical industry, and the environment; Development of products being genetic approaches effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of biotechnological processes to regulate, modulate, and characterize cell function or disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the pharmaceutical, chemical, biochemical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; Gene therapy services for others for product development and scient...
Medical services; Medical services, namely, gene therapy services